These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bleeding time and oral anticoagulant therapy. Marongiu F; Biondi G; Sorano GG; Mameli G; Conti M; Mamusa AM; Balestrieri A Thromb Haemost; 1993 May; 69(5):523-4. PubMed ID: 8357429 [No Abstract] [Full Text] [Related]
7. Thrombin activity and oral anticoagulant therapy: a preliminary study. Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Sanna MP; Farci P; Balestrieri A Haemostasis; 1989; 19(3):142-6. PubMed ID: 2744630 [TBL] [Abstract][Full Text] [Related]
8. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P; Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130 [TBL] [Abstract][Full Text] [Related]
10. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163 [TBL] [Abstract][Full Text] [Related]
11. Bleeding during oral anticoagulant therapy: warning against a greater hazard. Lavítola Pde L; Spina GS; Sampaio RO; Tarasoutchi F; Grinberg M Arq Bras Cardiol; 2009 Aug; 93(2):174-9. PubMed ID: 19838496 [TBL] [Abstract][Full Text] [Related]
12. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time. Nilsson CU; Strandberg K; Reinstrup P Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060 [TBL] [Abstract][Full Text] [Related]
13. Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates. Gruber A; Carlsson S; Kotzé HF; Marzec U; Sarich TC; Hanson SR Thromb Res; 2007; 119(1):121-7. PubMed ID: 16448687 [TBL] [Abstract][Full Text] [Related]
14. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. van Ryn J; Stangier J; Haertter S; Liesenfeld KH; Wienen W; Feuring M; Clemens A Thromb Haemost; 2010 Jun; 103(6):1116-27. PubMed ID: 20352166 [TBL] [Abstract][Full Text] [Related]
15. Use of oral anticoagulants in older patients. Sebastian JL; Tresch DD Drugs Aging; 2000 Jun; 16(6):409-35. PubMed ID: 10939307 [TBL] [Abstract][Full Text] [Related]
16. [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause]. Fontana S; Zeerleder S; Lämmle B Ther Umsch; 1999 Sep; 56(9):477-80. PubMed ID: 10517112 [TBL] [Abstract][Full Text] [Related]
17. Basic hemostatic parameters in patients with long-term oral anticoagulation undergoing cholecystectomy. Koc U; Bostanci EB; Karaman K; Ercan M; Dalgic T; Ulas M; Ozer I; Ozogul YB; Ayaz S; Haznedaroglu I; Akoglu M J Laparoendosc Adv Surg Tech A; 2011 Jun; 21(5):417-25. PubMed ID: 21486113 [TBL] [Abstract][Full Text] [Related]
18. The bleeding time in pediatrics. Sutor AH Semin Thromb Hemost; 1998; 24(6):531-43. PubMed ID: 10066148 [TBL] [Abstract][Full Text] [Related]
19. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
20. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience. Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]